CannapharmaRx Inc. (CPMD)
OTC PINK OTC PINK Primary Summary
CPMD Chart
CannapharmaRx to Complete Additional Shipment in November
CALGARY, AB / ACCESSWIRE / November 5, 2024 / CannaPharmaRX, Inc. (OTC PINK:CPMD), a future leader in cutting-edge, highly efficient cannabis production, is pleased to announce continued progress at its Cremona, Alberta facility, where cannabis cultivation remains on track according to the company's annual plan. Following the resignation of CEO Dean Medwid in early September, the company has been able to maintain uninterrupted operations while fulfilling and delivering its orders.
CannaPharmaRx Receives Multiple Purchase Orders and Begins Delivery of Product
CALGARY, AB / ACCESSWIRE / August 15, 2024 / CannaPharmaRx, Inc. (OTC PINK:CPMD), a future leader in ultramodern, highly efficient cannabis production facilities announced today that it has received three purchase orders for cannabis, for a total of 600KG, from Cantek Holdings. These orders are related to a previously announced supply agreement, and we are happy to announce that the market has proven to be pleased with our quality craft growing methodologies.
Q1 2024 Financial Results
CannaPharmaRx Announces Q1 2024 Financial Results Showcasing Commencement of Revenue CALGARY, AB / ACCESSWIRE / June 28, 2024 / CannaPharmaRx, Inc. (OTC PINK:CPMD), a future leader in ultramodern, highly efficient cannabis production facilities announced today that it filed its first quarter 2024 financial reports for the quarter ending March 31, 2024, on Tuesday, June 25, 2024. Q1 2024 Financial Highlights: Revenue of $25,839 versus $0 in the comparable period of 2023 due to the beginning of product sales.
CannapharmaRx Inc. (CPMD) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has CannapharmaRx Inc. ever had a stock split?
CannapharmaRx Inc. Profile
| Specialty Retail Industry | Consumer Discretionary Sector | Constantine Nkafu CEO | OTC PINK Exchange | 13765D109 CUSIP |
| CA Country | 26 Employees | - Last Dividend | 10 Nov 2006 Last Split | - IPO Date |
Overview
CannaPharmaRX, Inc. is a forward-looking company engaged in the evaluation, negotiation, acquisition, and development of various cannabis cultivation projects. Based in Calgary, Canada, the company leverages the favorable regulatory environment in Canada to engage in the burgeoning cannabis industry. By focusing on constructing and operating facilities designed to produce high-quality cannabis, CannaPharmaRX aims to meet the growing demand for medical and recreational cannabis products. The strategic location in Canada, a pioneer in cannabis legalization, provides the company with significant opportunities for growth and expansion in the cannabis sector.
Products and Services
- Cannabis Cultivation
CannaPharmaRX specializes in cultivating high-quality cannabis by employing advanced agricultural technologies and practices. The company's cultivation operations are designed to produce a wide range of cannabis strains, each tailored to meet specific customer needs and preferences. The focus is on ensuring the purity, potency, and consistency of their cannabis products.
- Project Development
Aside from cultivation, CannaPharmaRX is engaged in the evaluation and development of cannabis cultivation projects. This includes negotiating acquisitions or partnerships with other entities within the cannabis industry to expand its operational footprint. By continuously assessing new projects, the company aims to enhance its production capabilities and diversify its product offerings.
